Podcasts by Advances at Mass General Cancer Center
This podcast is a companion to Mass General Cancer Center’s electronic publication, and both are centered around our investigators recent publications in high-profile journals. Each expert will give you insight into who they are and what inspires them to do what they do every day. A deeper dive into their research will better your understanding of where our experts’ ideas come from, where they will go from here, and what the future has in store in their particular field of research.
Further podcasts by Advances at Mass General Cancer Center
Podcast on the topic Wissenschaft
All episodes
49. The impact and next steps for research led by Shannon Stott, PhD, and Brian Nahed, MD, MSc from 2018-11-09T19:45:39
Drs. Shannon Stott and Brian Nahed explain why their new technology is an important breakthrough for glioblastoma patients, and share what’s next for their research.
Listen
48. New techniques for capturing EVs from glioblastoma w/ Shannon Stott, PhD, & Brian Nahed, MD, MSc from 2018-11-09T19:43:12
Drs. Shannon Stott and Brian Nahed describe a new technique that uses microfluidics and engineered nanosurfaces to capture EVs released from glioblastoma multiforme, the most common and aggressive ...
Listen
47. Getting to know Shannon Stott, PhD, and Brian Nahed, MD, MSc from 2018-11-09T19:39:39
In this episode, Drs. Shannon Stott and Brian Nahed explain their backgrounds and share how they met and began working with each other.
Listen
46. The impact of the study on transit tumor cells through lymph node vasculature from 2018-10-02T15:13:39
In this episode, Ethel Pereira and Tim Padera share why the protocol in this study isn’t safe to use for humans yet, and what the next steps will advance the research to improve patient care.
Listen
45. Transit Tumor Cells Through Lymph Node Vasculature with Ethel Pereira, PhD, and Tim Padera, PhD from 2018-10-02T15:11:05
Tim Padera, PhD, and research fellow, Ethel Pereira, PhD, provide insight into their study of transit tumor cells.
Listen
44. Getting to know Tim Padera, PhD from 2018-10-02T15:09
Listen to hear how Tim Padera made his way from being an engineer in Chicago to becoming a cancer researcher in Boston.
Listen
43. Getting to know Ethel Pereira, PhD from 2018-10-02T15:06:56
In this episode we’ll hear about Ethel Pereira’s background and how she became interested in science, and specifically in cancer research.
Listen
40. Getting to know David Miyamoto, MD, PhD from 2018-08-15T21:31:33
In this episode, Dr. David Miyamoto shares how his parents met and explains the journey of how he ended up at the Mass General Cancer Center.
Listen
42. The future of David Miyamoto, MD, PhD, and his team’s research from 2018-08-15T19:35:57
Dr. David Miyamoto explains the impact of his research in prostate cancer, and mentions how it can potentially translate to bladder cancer.
Listen
41. New Technologies for Prostate Cancer with David Miyamoto, MD, PhD from 2018-08-15T19:33:04
Dr. David Miyamoto explains his study that examines new technology for treating prostate cancer.
Listen
39. What’s next for Ryan Corcoran, MD, PhD, his team, and their research from 2018-06-28T20:38:47
Dr. Ryan Corcoran talks about where his research is going and why it is so important to understanding divergent resistance mechanisms.
Listen
38. Divergent Resistance Mechanisms in Metastases with Ryan Corcoran, MD, PhD from 2018-06-28T20:12:30
Listen to Dr. Ryan Corcoran as he explains two of his studies, the first is about a way to treat a range of resistance strategies within BRAF mutations, and the second is about a novel pooled clone...
Listen
37. Getting to Know Ryan Corcoran, MD, PhD from 2018-06-28T20:07:28
In this episode, we’ll hear about Dr. Ryan Corcoran’s personal journey and how he came to the Mass General Cancer Center after growing up in California.
Listen
36. What’s next for Lee Zou, PhD, and his team from 2018-06-04T06:44:12
Dr. Lee Zou explains why understanding ATR inhibition in tumor cells is important, and shares what’s next for him and his team.
Listen
35. ATR Inhibition in Tumor Cells with Lee Zou, PhD from 2018-06-04T06:42:05
Listen to learn about the discovery Dr. Lee Zou and his team made regarding mitosis and ATR inhibition in tumor cells.
Listen
34. Getting to Know Lee Zou, PhD from 2018-06-04T06:40:17
In this episode, we learn about Dr. Lee Zou’s childhood in China and how his parents impacted his decision to make a career out of science.
Listen
33. What’s next for Miguel Rivera, MD, and his team from 2018-04-04T22:00:46
Dr. Miguel Rivera explains the future of Ewing Sarcoma and shares the importance of finding ways to make reactions between proteins more efficient inside the cell.
Listen
32. Activation of Ewing Sarcoma Oncogenes with Miguel Rivera, MD from 2018-04-04T21:57:26
Listen to Dr. Miguel Rivera who explains why prion-like domains in mutant EWS-Fli-1 fusion proteins are instrumental in activating Ewing Sarcoma oncogenes.
Listen
31. Getting to Know Miguel Rivera, MD from 2018-04-04T21:54:59
In this episode, we’ll hear about Miguel’s background, his interest in science and medicine, and what path he’s taken to get to where he is today.
Listen
30. Nir Hacohen, PhD, explains what’s next for immunotherapy research and therapies from 2018-03-06T18:47:20
Dr. Nir Hacohen explains where he sees cancer immunotherapy research and therapies going in the future, and what he thinks is next for his team and his lab.
Listen
29. Immune Checkpoint Blockade Therapy in Metastatic Melanoma with Nir Hacohen, PhD from 2018-03-06T18:43:31
Learn about how Dr. Nir Hacohen’s lab works to understand mechanism underline resistance to immune check point blockade therapy in metastatic melanoma and how his lab is setting the ground work for...
Listen
28. Getting to know why and how Nir Hacohen, PhD, joined the Mass General Cancer Center from 2018-03-06T18:40:33
Listen to Dr. Nir Hacohen as he remembers his recruitment to the Mass General Hospital and what brought him to join the Mass General Cancer Center.
Listen
27. What’s Next for Priscilla Brastianos, MD, and Her Clinical Trials from 2018-01-31T21:51:10
Dr. Priscilla Brastianos gives a detailed account of the clinical trials that she has opened at the Mass General Cancer Center.
Listen
26. New Genetic-Based Treatment for Glioneuronal Tumors with Priscilla Brastianos, MD from 2018-01-31T21:40:22
Listen to Dr. Priscilla Brastianos as she explains her studies on new genetic-based treatment for glioneuronal tumors and glioblastoma.
Listen
25. Getting to Know Priscilla Brastianos, MD from 2018-01-31T21:33:32
Learn more about Dr. Priscilla Brastianos’ interesting background including her Greek and Canadian upbringing, why she became an oncologist, and what drives her every day to make advances in cancer...
Listen
24. What’s Next for Othon Iliopoulos, MD, and His Research from 2018-01-03T19:29:33
Hear what Dr. Othon Iliopoulos has planned in regards to combination therapy for renal cell carcinoma, as well as his medical efforts in Greece.
Listen
23. Combination Therapy for Renal Cell Carcinoma with Othon Iliopoulos, MD from 2018-01-03T19:26:29
Dr. Othon Iliopoulos explains his team’s recent findings on combination therapy for renal cell carcinoma and explains the clinical relevance to this discovery.
Listen
22. Getting to Know Othon Iliopoulos, MD from 2018-01-03T19:23:57
Listen to learn about Dr. Othon Iliopoulos’ interesting background, including his passion for social activism, and his efforts to build a science community in Greece.
Listen
21. What’s next for Lipika Goyal, MD and her research? from 2017-11-27T22:02:48
Listen to find out how Lipika Goyal, MD, will be continuing her research, what drugs are on the horizon, and what’s next for her.
Listen
20. Investigating biliary duct cancer mutations with Lipika Goyal, MD from 2017-11-27T22:00:04
Listen to Dr. Lipika Goyal discuss her research of the genetic mechanisms that drive resistance and that may lead to better therapies for bile duct and other cancers.
Listen
19. Getting to Know Lipika Goyal, MD from 2017-11-27T21:53:22
Listen to learn about Dr. Lipika Goyal’s educational and personal background and why she chose the path that she did.
Listen
18. What’s Next for Mario Suvà, MD, PhD, and His Research from 2017-10-31T15:20
Hear more about what’s next for this line of work, and about where Dr. Mario Suvà sees things going in this field of research.
Listen
17. Identifying Therapeutic Targets for IDH-Mutant Brain Tumors with Mario Suvà, MD, PhD from 2017-10-31T15:11:33
Learn more about Dr. Mario Suvà’s work on single-cell RNA sequencing of IDH-mutant glioma samples and how identifying cell lineages, phenotypes, and microenvironments may lead to new therapies.
Listen
16. Getting to Know Mario Suvà, MD, PhD from 2017-10-31T15:09:55
Learn about Dr. Mario Suvà’s educational and personal background and what sparked his interest in medicine and science.
Listen
15. The future directions with Nabeel Bardeesy, PhD from 2017-10-12T21:30:53
Listen to find out about the future direction of Nabeel Bardeesy’s research, and the exciting application of his team’s findings to launch a new clinical trial.
Listen
14. Epigenetic-Metabolic Pathways in Pancreatic Tumor Cells with Nabeel Bardeesy, PhD from 2017-10-12T21:28:41
Hear more from Nabeel Bardeesy about the discovery of a novel epigenetic-metabolic pathway that suggest therapeutic targets in tumors with combined KRAS and LKB1 mutations.
Listen
13. Getting to know Nabeel Bardeesy, PhD from 2017-10-12T21:26:03
Learn more about his background and how he became interested in science.
Listen
12. Future Direction of HER2 Cells in Breast Cancer w/ Aditya Bardia, MD & Shyamala Maheswaran, PhD from 2017-08-25T19:26:11
In this episode, Drs. Aditya Bardia and Shyamala Maheswaran explain the next steps in their study and what it will take to keep advancing their research of HER2 cells.
Listen
11. When HER2 Cells Adapt in Breast Cancer with Aditya Bardia, MD and Shyamala Maheswaran, PhD from 2017-08-25T19:22:20
In this episode, we talk with Drs. Aditya Bardia and Shyamala Maheswaran about their recently published study showing that breast cancer cells can spontaneously switch from a HER2-positive to a HER...
Listen
10. Getting to know Aditya Bardia, MD, and Shyamala Maheswaran, PhD from 2017-08-25T19:16:15
In this episode, Drs. Aditya Bardia and Shyamala Maheswaran discuss their unique backgrounds, including why they came to the United States and what led them to where they are today.
Listen
9. The Future of Palliative Care for Curative Intent with Areej El-Jawahri, MD from 2017-07-25T17:38:35
In this episode, Areej El-Jawahri, MD, discusses the future of palliative care for curative intent, her plans to continue with a replication study, and what’s required to move things forward.
Listen
8. Palliative Care: The Potential Benefit for Patients with Areej El-Jawahri, MD from 2017-07-25T17:36:40
In this episode, Areej El-Jawahri explains hematopoietic stem cell transplantation and her study showing why palliative care can be beneficial to patients and their family members.
Listen
7. Getting to Know Areej El-Jawahri, MD from 2017-07-25T17:34:15
In this episode, Areej El-Jawahri, MD, discusses her personal background and her career path, both of which have conventional and unique characteristics.
Listen
6. The Future of Immunology in Cancer Care with Nir Hacohen, PhD from 2017-05-26T20:12:22
Nir Hacohen, PhD, talks more about immunology and how it may impact the future of cancer care.
Listen
5. Immunology: Paving the Way to New Cancer Treatments with Nir Hacohen, PhD from 2017-05-26T20:04:59
Nir Hacohen, PhD, walks us through his recent research findings and helps us understand how these and related discoveries have already paved the way to novel cancer treatments.
Listen
4. Getting to Know Nir Hacohen, PhD from 2017-05-26T20:03:14
Nir Hacohen, PhD, talks about how he got started in science and immunology. We also find out what drives him day in and day out.
Listen
3. The Future of Epigenetic Research with Raul Mostoslavsky, MD, PhD from 2017-05-26T20:00:45
Raul Mostoslavsky, MD, PhD, discusses where he sees the field of epigenetic research going in the future.
Listen
2. New Therapeutic Targets for Pancreatic Cancer with Raul Mostoslavsky, MD, PhD from 2017-05-26T19:51:42
Raul Mostoslavsky, MD, PhD, digs deeper into his recent publication on new therapeutic targets for pancreatic cancer.
Listen
1. Getting to Know Raul Mostoslavsky, MD, PhD from 2017-05-26T19:49:16
Raul Mostoslavsky, MD, PhD, discusses his journey, his culture, and what led him to pursue research.
Listen